Normal view MARC view ISBD view

Cost-effectiveness of rituximab strategies in rheumatoid arthritis.

Seror, Raphaèle

Cost-effectiveness of rituximab strategies in rheumatoid arthritis. [electronic resource] - Lancet (London, England) 01 2017 - 365-366 p. digital

Publication Type: Letter; Comment

ISSN: 1474-547X

Standard No.: 10.1016/S0140-6736(17)30053-3 doi

Subjects--Topical Terms:
Antirheumatic Agents
Arthritis, Rheumatoid
Cost-Benefit Analysis
Humans
Rituximab

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)